Navigation Links
Large-Scale Survey Reveals Low Sexual Desire Most Common Distressing Female Sexual Problem, Affecting Up to One in 10 Women
Date:10/31/2008

RIDGEFIELD, Conn., Oct. 31 /PRNewswire/ -- Results from PRESIDE (Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking), the largest survey assessing the prevalence of female sexual problems, show that low sexual desire is the most commonly reported sexual problem in women age 18 or older. In this new national survey of more than 31,000 women in the United States, published today in Obstetrics & Gynecology (the Green Journal), nearly one in 10 women reported low desire with sexually-related personal distress, a problem that can be a primary medical condition known as Hypoactive Sexual Desire Disorder (HSDD) or secondary to other chronic medical conditions (e.g., depression, thyroid conditions) or medication use. Participants in this survey were not clinically evaluated by a healthcare professional to determine the underlying causes of the reported sexual problems.

HSDD remains largely under-diagnosed in the United States. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, defines HSDD as the persistent lack (or absence) of sexual fantasies or desire for any form of sexual activity marked by distress or interpersonal difficulty and not better accounted for by another disorder (except another sexual dysfunction), direct physiological effects of a substance (including medications) or a general medical condition.

"Physicians who diagnose and treat women with sexual problems should also make sure to evaluate the patient's level of distress associated with her problem," said Jan L. Shifren, M.D., lead author of the study and director, Menopause Program, Vincent Obstetrics and Gynecology Service at Massachusetts General Hospital, Boston. "As distressing sexual problems were identified in approximately one in eight women, healthcare providers need to ask their patients about sexual concerns, and whether they are causing unhappiness, frustration or other distressing feelings that may be impacting their quality of life."

PRESIDE Results

In the PRESIDE survey, 44.2 percent of women reported experiencing any sexual problem. Low desire was most common, reported in 38.7 percent of all respondents; low arousal (26.1%) and orgasm difficulty (20.5%) were less frequent. Of all the women surveyed, 22.8 percent said they had sexually-related personal distress.

One in eight women (12%) said they had either low desire, low arousal or orgasm difficulty plus personal distress, meaning that, for example, the sexual issue caused the woman to feel frustrated, stressed, angry, embarrassed or unhappy. Low desire was the most common distressing sexual problem, affecting 10 percent of respondents, followed by arousal plus distress (5.4%) and orgasm difficulty plus distress (4.7%). Younger women (ages 18-44; 10.8%) and middle-aged women (45-64; 14.8%) were more likely to suffer a distressing sexual problem than older women (65+; 8.9%). In addition, these women tended to have poor self-assessed health and a low level of education as well as other health issues such as depression, anxiety, thyroid conditions and urinary incontinence.

About PRESIDE

PRESIDE is a cross-sectional, population-based, nationally-representative survey of 31,581 adult women in the United States.

As female sexual dysfunction is characterized by sexual problems associated with personal distress, two validated instruments were used. The Changes in Sexual Functioning Questionnaire (CSFQ-14), a 14-item validated tool, was used to capture a respondent's self-evaluation of current sexual behaviors and problems using a five-point scale. The Female Sexual Distress Scale (FSDS), a 12-item validated tool, measures a woman's distress about her sex life, assesses guilt, frustration, stress, worry, anger, embarrassment and unhappiness during the past 30 days.

Funding for PRESIDE was provided by Boehringer Ingelheim.

Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com.


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Illinois Meth Project Launches Large-Scale Meth Prevention Campaign
2. NIH report on intracranial stent points out need for upcoming large-scale clinical trial
3. Survey reveals disparities in skin cancer knowledge, protection among high school students
4. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
7. Youth Drug Use at a Five Year Low, New Survey Shows
8. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
9. Parental surveys boost diagnosis abilities of pediatricians
10. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
11. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... 2016 , ... Each year, the American Physical Therapy Association (APTA) offers a ... Anaheim Convention Center. Almost 10,000 physical therapists across the country are expected to attend ... about their chosen field and network with their colleagues. As in years past, ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, ... real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... Colorado (PRWEB) , ... February 12, 2016 , ... Vail ... ASC Industry Physician Leaders to Know in 2016 . The list consists of physicians ... nominated physicians to establish this list. , An Ambulatory Surgery Center, also known ...
(Date:2/12/2016)... ... ... For Coast Dental dentist Everet Lake, DDS, the smiles began at dawn. He ... 7 a.m. to volunteer at Friday’s Dentistry from the Heart event in New Port ... hundreds of uninsured and underinsured people receive much-needed dental care. , This was ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ) is pleased to announce the promotion of ... Strategies effective Jan. 23, 2016. To learn ... ... ... ...
(Date:2/12/2016)...  SI-BONE, Inc., a medical device company that pioneered the use ... surgical (MIS) device indicated for fusion for certain disorders of the ... Medicare Administrative Contractor (MAC) covering the states of Connecticut ... , Massachusetts , Minnesota , ... , Rhode Island , Vermont ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. ... Macrogen, Inc. today announced they will form a ... for precision medicine in cancer. The goal of ... digital-sorting technology with Macrogen,s high-throughput Next Generation Sequencing ... the Clinical Laboratory Improvement Amendments (CLIA) of 1988 ...
Breaking Medicine Technology: